ArticleTherapeutic advances in respiratory disease

Characteristics of initiators of budesonide/glycopyrrolate/formoterol for treatment of chronic obstructive pulmonary disease (COPD) in the United States: the AURA study.

Edward C Portillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.